loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2000_161___rev_03 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Bayer AG

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 BAYER PHARMA AG Berlin DE (1)

    filter

    01 Aprotinin concentrated solution (1)

    filter

    01 Germany (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    BAYER PHARMA AG Berlin DE

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Aprotinin concentrated solution

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2000-161 - Rev 03
    Withdrawn by Holder
    Chemical and TSE
    2011-09-15
    2017-05-15
    579
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2000-161 - Rev 03 of Bayer Pharma Ag Berlin De

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2000-161 - Rev 03 of Bayer Pharma Ag Berlin De 1

    20

    Bayer Pharma Ag Berlin De, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their significant offerings is Aprotinin concentrated solution, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2000-161 - Rev 03

    This Chemical and TSE Type CEP, issued on September 15, 2011, remains in force until May 15, 2017, ensuring its reliability within the pharmaceutical industry.

    Substance Number 579 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY